Showing results (331-340 of 376) with videos related to

Sort By:
Pageof 38
Journal of Hepatology|January 23, 2022
Factor VIII/protein C ratio independently predicts liver-related events but does not indicate a hypercoagulable state in ACLDBernhard Scheiner, Lorenz Balcar, Rosa Johanna Nussbaumer, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|July 16, 2024
Prediction model for leaflet thrombosis in patients undergoing transcatheter aortic valve implantation: the EFFORT studyGloria M Steiner-Gager, Jovan Rogozarski, Christina Kronberger, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 20, 2024
Performance of Diagnostic Algorithms in Patients With Invasive Pulmonary AspergillosisStefan Hatzl, Christina Geiger, Lisa Kriegl, et al.
Viruses|February 26, 2022
Venous Thrombosis within 30 Days after Vaccination against SARS-CoV-2 in a Multinational Venous Thromboembolism RegistryBehnood Bikdeli, David Jiménez, Pablo Demelo-Rodriguez, et al.
JACC. Cardiooncology|January 13, 2025
Early Change in C-Reactive Protein and Venous Thromboembolism in Patients Treated With Immune Checkpoint InhibitorsFlorian Moik, Jakob M Riedl, Dominik Barth, et al.
Leukemia|February 22, 2023
Human gene-engineered calreticulin mutant stem cells recapitulate MPN hallmarks and identify targetable vulnerabilitiesJohannes Foßelteder, Gabriel Pabst, Tommaso Sconocchia, et al.
Thrombosis Research|September 20, 2020
ETNA-VTE Europe: Benefits and risks of venous thromboembolism treatment using edoxaban in the first 3 monthsGiancarlo Agnelli, Ulrich Hoffmann, Philippe Hainaut, et al.
European Journal of Internal Medicine|August 23, 2020
ETNA VTE Europe: A contemporary snapshot of patients treated with edoxaban in clinical practice across eight European countriesAlexander T Cohen, Ulrich Hoffmann, Philippe Hainaut, et al.
Thrombosis and Haemostasis|September 10, 2021
New Inhibitors in the Ageing Population: A Retrospective, Observational, Cohort Study of New Inhibitors in Older People with HemophiliaJan Astermark, Cihan Ay, Manuela Carvalho, et al.
Pageof 38